User:Julie A. Fogarty: Difference between revisions
m (→Education) |
|||
| (14 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Julie A. Fogarty== | ==Julie A. Fogarty== | ||
[[Image:JAF_ATX.jpg|thumb|300px|right|"Science does not know its debt to imagination." -Ralph Waldo Emerson]] | [[Image:JAF_ATX.jpg|thumb|300px|right|"Science does not know its debt to imagination." -Ralph Waldo Emerson]] | ||
Gerald J. Lieberman Fellow <br> | |||
NSF Graduate Research Fellow <br> | NSF Graduate Research Fellow <br> | ||
Chemical Engineering <br> | Chemical Engineering <br> | ||
Stanford University <br> | Stanford University <br> | ||
[ | [http://web.stanford.edu/group/swartz/index.html Swartz] Lab | ||
==Contact Info== | ==Contact Info== | ||
'''Email:''' <br> | '''Email:''' <br> | ||
julie.fogarty {at} alumni.stanford.edu | |||
==Education== | ==Education== | ||
* | * 2019 - PhD Chemical Engineering, Stanford University | ||
* 2015 | * 2015 - MS Chemical Engineering, Stanford University | ||
* 2013 - BS Chemical Engineering, The University of Texas at Austin | * 2013 - BS Chemical Engineering, The University of Texas at Austin | ||
| Line 25: | Line 20: | ||
# Protein Engineering | # Protein Engineering | ||
# Vaccine Development & Immunology | # Vaccine Development & Immunology | ||
# Biotechnology Process Development <br> | # Biotechnology Process Development <br> | ||
Julie is working on developing a modular virus-like particle approach for creating novel vaccine candidates for HIV, Influenza, and Zika. The HIV work is a collaboration with Prof. [http://www.stanford.edu/group/kimlab/ Peter Kim] at Stanford University. She is also working on developing the virus-like particles as a modular platform for targeted T-cell antigen delivery in collaboration with Prof. [http://elias.stanford.edu/index.php?tab=home Josh Elias]. | |||
==Funding Sources== | |||
HIV Vaccine - [https://biox.stanford.edu/research/seed-grants/initial-feasibility-determination-novel-aids-vaccine Stanford BioX Program] <br> | |||
Influenza Vaccine - [http://med.stanford.edu/chri.html Child Health Research Institute], through the [http://med.stanford.edu/sparkmed.html Stanford SPARK Program] and the Weston Havens Foundation <br> | |||
Zika Vaccine - [http://med.stanford.edu/sparkmed.html Stanford SPARK Program] <br> | |||
Julie's Personal Funding - [https://www.nsfgrfp.org/ NSF Graduate Research Fellowship Program], [https://vpge.stanford.edu/fellowships-funding/gerald-j-lieberman-fellowship/details Gerald J. Lieberman Fellowship] | |||
==Past Research Experience== | ==Past Research Experience== | ||
[https:// | [https://www.maynardlabatut.com/ Maynard Lab], The University of Texas at Austin, (Sept. 2011 - Aug. 2013) <br> | ||
[http://www.che.utexas.edu/research/biomat/index.htm Peppas Lab], The University of Texas at Austin, (Nov. 2009 - May 2011) <br> | [http://www.che.utexas.edu/research/biomat/index.htm Peppas Lab], The University of Texas at Austin, (Nov. 2009 - May 2011) <br> | ||
[http://www.mdanderson.org/education-and-research/departments-programs-and-labs/labs/calin-lab/index.html Calin Lab], M.D. Anderson Cancer Center, (June & July 2008) | [http://www.mdanderson.org/education-and-research/departments-programs-and-labs/labs/calin-lab/index.html Calin Lab], M.D. Anderson Cancer Center, (June & July 2008) | ||
==Publications== | ==Publications== | ||
1. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, and Calin GA. ''miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.'' Cell Death Differ. 2010 Feb;17(2):246-54. [http://dx.doi.org/10.1038/cdd.2009.117 DOI:10.1038/cdd.2009.117]|[https://www.ncbi.nlm.nih.gov/pubmed/19730444?dopt=Abstract PubMed ID: 19730444]|[http://www.hubmed.org/display.cgi?uids=19730444 HubMed] | |||
< | <br> | ||
<br> | |||
</ | 2. Fogarty JA and Swartz JR. ''The exciting potential of modular nanoparticles for rapid development of highly effective vaccines''. Curr Opin Chem Eng. 2018 Mar;19:1-8. [http://dx.doi.org/10.1016/j.coche.2017.11.001 DOI:10.1016/j.coche.2017.11.001] | ||
==Press About Julie== | |||
'''04 Mar 2016''' [http://healthier.stanfordchildrens.org/en/robot-bridges-gap-young-patients-isolation-hospital-school-peers/ Robot bridges the gap between young patients on isolation and hospital school peers, Lucile Packard Children's Hospital Healthier, Happy Lives Blog] <br> | |||
'''20 Mar 2015''' [http://nationalsciencefoundation.tumblr.com/post/114134707453/getting-her-hands-dirty Getting her hands dirty, National Science Foundation] <br> | |||
'''19 Dec 2014''' [http://scopeblog.stanford.edu/2014/12/19/science-friday-style-podcast-explains-work-toward-a-universal-flu-vaccine/ Science Friday-style podcast explains work toward a universal flu vaccine, Stanford Medicine Scope Blog] <br> | |||
'''26 Apr 2013''' [http://www.engr.utexas.edu/news/releases/7599-texas-exes-presidents-leadership-awards-2013 Three Cockrell School Seniors Receive President’s Leadership Awards, University of Texas Cockrell School of Engineering] <br> | |||
'''28 Nov 2012''' [http://www.che.utexas.edu/2012/11/28/undergraduate-julie-fogarty-wins-commended-synthetic-biology-presentation-award/ Undergraduate Julie Fogarty Wins Commended Synthetic Biology Presentation Award, University of Texas McKetta Department of Chemical Engineering] <br> | |||
Latest revision as of 23:54, 16 August 2020
Julie A. Fogarty
Gerald J. Lieberman Fellow
NSF Graduate Research Fellow
Chemical Engineering
Stanford University
Swartz Lab
Contact Info
Email:
julie.fogarty {at} alumni.stanford.edu
Education
- 2019 - PhD Chemical Engineering, Stanford University
- 2015 - MS Chemical Engineering, Stanford University
- 2013 - BS Chemical Engineering, The University of Texas at Austin
Research Interests
- Protein Engineering
- Vaccine Development & Immunology
- Biotechnology Process Development
Julie is working on developing a modular virus-like particle approach for creating novel vaccine candidates for HIV, Influenza, and Zika. The HIV work is a collaboration with Prof. Peter Kim at Stanford University. She is also working on developing the virus-like particles as a modular platform for targeted T-cell antigen delivery in collaboration with Prof. Josh Elias.
Funding Sources
HIV Vaccine - Stanford BioX Program
Influenza Vaccine - Child Health Research Institute, through the Stanford SPARK Program and the Weston Havens Foundation
Zika Vaccine - Stanford SPARK Program
Julie's Personal Funding - NSF Graduate Research Fellowship Program, Gerald J. Lieberman Fellowship
Past Research Experience
Maynard Lab, The University of Texas at Austin, (Sept. 2011 - Aug. 2013)
Peppas Lab, The University of Texas at Austin, (Nov. 2009 - May 2011)
Calin Lab, M.D. Anderson Cancer Center, (June & July 2008)
Publications
1. Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, and Calin GA. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010 Feb;17(2):246-54. DOI:10.1038/cdd.2009.117|PubMed ID: 19730444|HubMed
2. Fogarty JA and Swartz JR. The exciting potential of modular nanoparticles for rapid development of highly effective vaccines. Curr Opin Chem Eng. 2018 Mar;19:1-8. DOI:10.1016/j.coche.2017.11.001
Press About Julie
04 Mar 2016 Robot bridges the gap between young patients on isolation and hospital school peers, Lucile Packard Children's Hospital Healthier, Happy Lives Blog
20 Mar 2015 Getting her hands dirty, National Science Foundation
19 Dec 2014 Science Friday-style podcast explains work toward a universal flu vaccine, Stanford Medicine Scope Blog
26 Apr 2013 Three Cockrell School Seniors Receive President’s Leadership Awards, University of Texas Cockrell School of Engineering
28 Nov 2012 Undergraduate Julie Fogarty Wins Commended Synthetic Biology Presentation Award, University of Texas McKetta Department of Chemical Engineering
